IMUX
Immunic·NASDAQ
--
--(--)
--
--(--)
IMUX Filings
Filing Date
Form Description
Form Type
2026-04-01
Form 8-K - Current report
Key Events
2026-04-01 · Key Events
Form 8-K - Current report
2026-03-31
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-31 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-03-31
Form 8-K - Current report
Key Events
2026-03-31 · Key Events
Form 8-K - Current report
2026-03-04
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-04 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-04
Form D - Notice of Exempt Offering of Securities
2026-03-04 ·
Form D - Notice of Exempt Offering of Securities
2026-03-02
Form DEF 14A - Other definitive proxy statements
Key Events
2026-03-02 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-02-27
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-02-27 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-02-27
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-02-27 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-02-26
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-26 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-26
Form 8-K - Current report
Key Events
2026-02-26 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
